TriNutra received approval from the Thailand Fodo and Drug Administration (TFDA) to market its ThymoQuin branded black seed oil as a novel food to be sold in dietary supplements, after the agency found it in compliance with Ministry of Public Health standards.
 
The ingredient is the first cold-pressed Nigella sativa oil standardized to contain 3% thymoquinone with a low free fatty acids content of less than 1.25%.
 
“We are incredibly proud to reveal this achievement in Thailand,” said Morris Zelkah, CEO of TriNutra. “The sales and awareness of black seed oil continue to grow, and with our exclusive Thailand distribution partner, Aumento Chemical Ltd., we can now offer our clinically studied, high quality, potent, and bioavailable black seed oil to Thai residents.”
 
The TFDA was established under the Ministry of Public Health to oversee the manufacturing, import, and distribution of regulated products to ensure they comply with safety and quality standards.
 
“ThymoQuin offers the highest quality black seed oil with clinically validated health benefits,” said Watcharee Saponowong, managing director of Aumento Chemical Ltd. “We are happy to provide this powerful ingredient to our Thailand residents for improved health and wellbeing. We have the TFDA registration numbers and welcome customers to contact us for more information.” 
 
Thymoquin is a full-spectrum composition which meets USP monographs and has been evidenced to beneficially modulate inflammatory response, improve mitochondrial activity including ATP production, and exert certain antioxidant and anti-microbial effects, TriNutra reports.